This product was clinicially tested in cardiac, general, hepatic, and orthopedic surgeries. Cohesion received the CE mark for CoStasis in September 1998 and launched CoStasis in Europe in early 1999. Marketing clearance was received from the FDA in June 2000, and distribution of CoStasis through United States Surgical began in July 2000.
Anastomotic leakage is especially common during cardiac and vascular procedures.
Cohesion received the CE Mark and launched CoSeal in Europe in 2000. Inc. All rights reserved.